I dont believe cancer vaccines are in the interest of GSK.
That was a reply I got around 6 - 8 months back when I highlighted PRR to Christopher Francis at GSK, who heads up the Oncology business development unit. Maybe times have changed or that was a throw away line..........
See the attached link and feel free to email him:
www.gsk.com/collaborations/downloads/WWBD-mini-brochure.pdf
watch ymyc tonight wed 14/3, page-6
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $1.805M | 5.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 193400 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |